Herpes zoster in inflammatory rheumatic diseases

被引:0
|
作者
Dartsch, Ruth Charlotte [1 ,2 ]
Al-Azem, Nadine [1 ,2 ]
Hasseli-Fraebel, Rebecca [1 ,2 ]
机构
[1] Univ Klinikum Munster, Med Klin D, Sekt Rheumatol, Albert Schweitzer Campus 1, D-48149 Munster, Germany
[2] Univ Klinikum Munster, Klin Immunol, Albert Schweitzer Campus 1, D-48149 Munster, Germany
关键词
herpes zoster; postherpetic neuralgia; immunomodulation; autoimmune disease; inflammation; RISK-FACTORS; POSTHERPETIC NEURALGIA; NEUROPATHIC PAIN; SUBUNIT VACCINE; GABAPENTIN; EFFICACY;
D O I
10.1055/a-2312-5481
中图分类号
R75 [皮肤病学与性病学];
学科分类号
100206 ;
摘要
Herpes zoster is a viral disease that commonly occurs after a prolonged period of latency due to reactivation of an initial varicella zoster infection. The disease mainly affects older adults and those with impaired immune systems. In the acute phase, individuals experience dermatome-linked pain and papulovesicular rash. The primary complication is excruciating postherpetic neuralgia, which can last several months to years. For precautionary purposes, an inactivated vaccine is available. This vaccine is recommended by the German Standing Committee on Vaccination (STIKO) for individuals with an increased risk profile starting at 50 years of age and as a routine vaccination for individuals aged 60 and older.
引用
收藏
页码:314 / 320
页数:7
相关论文
共 50 条
  • [31] HERPES ZOSTER INFECTION ACROSS AUTO-IMMUNE AND INFLAMMATORY DISEASES: IMPLICATIONS FOR VACCINATION
    Curtis, J. R.
    Yang, S.
    Chen, L.
    Winthrop, K.
    Xie, F.
    Baddley, J. W.
    Saag, K.
    Singh, J.
    Yun, H.
    [J]. ANNALS OF THE RHEUMATIC DISEASES, 2014, 73 : 452 - 452
  • [32] Long Term Effectiveness of Herpes Zoster Vaccine Among Patients with Autoimmune and Inflammatory Diseases
    Yun, Huifeng
    Xie, Fenglong
    Baddley, John
    Winthrop, Kevin L.
    Chen, Lang
    Curtis, Jeffrey R.
    [J]. ARTHRITIS & RHEUMATOLOGY, 2015, 67
  • [33] Suboptimal Vaccination Coverage with Influenza, Pneumococcal and Herpes Zoster Vaccines Among Adult Patients with Autoimmune Inflammatory Rheumatic Diseases in a Nationwide Health Care Plan
    Furer, Victoria
    Weil, Clara
    Orin, Melanie
    Chodick, Gabriel
    Shalev, Varda
    Shoval, Yonit Fisher
    Cohen, Raanan
    Elkayam, Ori
    [J]. ARTHRITIS & RHEUMATOLOGY, 2020, 72
  • [34] HERPES-ZOSTER AND HEART-DISEASES
    BAKHUR, VT
    [J]. KLINICHESKAYA MEDITSINA, 1983, 61 (05): : 36 - 39
  • [35] Inflammatory Bowel Disease and the Risk of Herpes Zoster
    Lai, Shih-Wei
    [J]. GUT AND LIVER, 2019, 13 (05) : 582 - 582
  • [36] Overall and Comparative Risk of Herpes Zoster With Pharmacotherapy for Inflammatory Bowel Diseases: A Nationwide Cohort Study
    Khan, Nabeel
    Patel, Dhruvan
    Trivedi, Chinmay
    Shah, Yash
    Lichtenstein, Gary
    Lewis, James
    Yang, Yu-Xiao
    [J]. CLINICAL GASTROENTEROLOGY AND HEPATOLOGY, 2018, 16 (12) : 1919 - +
  • [37] Herpes Zoster Infection Risk in Auto-Immune and Inflammatory Diseases: Implications for Vaccination.
    Yun, Huifeng
    Yang, Shuo
    Chen, Lang
    Xie, Fenglong
    Winthrop, K. L.
    Baddley, John
    Saag, Kenneth G.
    Singh, Jasvinder
    Curtis, Jeffrey R.
    [J]. ARTHRITIS & RHEUMATOLOGY, 2014, 66 : S360 - S361
  • [39] Herpes zoster following BNT162b2 mRNA COVID-19 vaccination in patients with autoimmune inflammatory rheumatic diseases: a case series
    Furer, Victoria
    Zisman, Devy
    Kibari, Adi
    Rimar, Doron
    Paran, Yael
    Elkayam, Ori
    [J]. RHEUMATOLOGY, 2021, 60 : SI90 - SI95
  • [40] Inflammatory rheumatic diseases in migrants
    Koetter, Ina
    Krusche, Martin
    [J]. INNERE MEDIZIN, 2023, 64 (05): : 426 - 434